Business
Pfizer’s COVID vaccine success is worth an extra $14 billion to the US pharma giant – ABC News
The success of Pfizer’s mRNA-based COVID vaccine looks set to secure the company a multi-billion-dollar windfall for many years as countries already start booking…
The success of its COVID vaccine, and the challenges faced by some of its rivals, look set to earn US pharmaceutical giant Pfizer at least an extra $US11 billion ($14.2 billion) in revenue this year.
Key points:
- Pfizer has raised its 2021 revenue forecasts for COVID vaccine sales by 73 per cent
- The company is hoping to ramp up production to 2.5 billion doses this year and three billion in 2022
- Pfizer is evaluating a prototype to include the South African variant and expects annual flu-style vaccinations…
Continue Reading
-
Noosa News23 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour
-
General21 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Business23 hours agoHow $1,000 a month in this ASX ETF could turn into $500,000
-
Noosa News23 hours agoGrow it local | Noosa Today